Startup India Government of India
Yapan Bio Private Limited - pharma in Shameerpet, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹55.8 Cr
▲ 87% YoY
Net profit · FY 2025
₹9.95 Cr
Net margin 17.8%
EBITDA · FY 2025
₹24.35 Cr
EBITDA margin 43.6%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹36 Lakh
Issued & subscribed
Open charges
₹10.53 Cr
Satisfied ₹6.25 Cr
Company age
7 yrs
Est. 2019
Employees · EPFO
49
Provident fund records
About Yapan Bio Private Limited
Data last updated:
Yapan Bio Private Limited is a private limited company based in Shameerpet, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74110TG2019PTC136037. Its GSTIN is 36AABCY1687M1ZQ (Telangana).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹36 Lakh. It is led by directors including Atin Tomar and Nirav Manoj Kumar Desai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shameerpet, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹55.8 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹9.95 Cr (net margin 17.8%) and EBITDA of ₹24.35 Cr (EBITDA margin 43.6%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 74% over five years.
The company has about 49 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Yapanbio. As per MCA filings, the company has open charges of ₹10.53 Cr and satisfied charges of ₹6.25 Cr on record. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹101.77 Cr; the latest was in December 2021.
Yapan Bio Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0005358). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website yapanbio.com.
Company details
CIN U74110TG2019PTC136037
Registration Number 136037
Incorporation Date 11 October 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0005358
Key People
Atin Tomar Director Nirav Manoj Kumar Desai Director Debasish Chakravorty Nominee Director Recognitions & Rankings of Yapan Bio
MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0005358
Contact details
Yapan Bio Private Limited's registered office is in Shameerpet, Telangana. Its website is yapanbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGround Floor Suite 3, 270 Touchstone Genome Valley Hyderabad, Shameerpet, Telangana, India – 500078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Yapan Bio Private Limited, buy the company report.
Comprehensive company report
Yapan Bio Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Yapan Bio operates one associated brand: Yapanbio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract manufacturing of bio-therapeutics and vaccines is provided. | yapanbio.com |
Business activity
The main business activity of Yapan Bio is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Yapan Bio Private Limited, buy the company report.
Financials of Yapan Bio Private Limited
FY 2025 filings availableYapan Bio Private Limited reported revenue of ₹55.8 Cr (up 87% YoY) for FY 2025.
Revenue · FY 2025
₹55.8 Cr ▲ 87%
Net profit · FY 2025
₹9.95 Cr margin 17.8%
EBITDA · FY 2025
₹24.35 Cr margin 43.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 87%
3 years · compounded
▲ 33%
5 years · compounded
▲ 74%
EBITDA CAGR growth
1 year
▲ 281%
3 years · compounded
▲ 18%
5 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 74% over five years, including 87% growth in the latest year. EBITDA rose 281% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.35 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.95 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.6% | ||||
| Net Profit Margin | 17.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yapan Bio Private Limited, buy the company report.
Board of directors of Yapan Bio Private Limited
Yapan Bio has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atin Tomar | Director | 11 Oct 2019 | 7 Years 0 Months | Current |
| Nirav Manoj Kumar Desai Also directs: Sunrise Efficient Marketing Limited, Reet Projects Limited | Director | 11 Oct 2019 | 7 Years 0 Months | Current |
| Debasish Chakravorty | Nominee Director | 12 Jan 2024 | 2 Years 9 Months | Current |
Auditor
Yapan Bio Private Limited is audited by Deloitte Haskins & Sells for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2023 | 003793S/S200089 |
Shareholding
The shareholding of Yapan Bio Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Yapan Bio Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.53 Cr
Satisfied charges
₹6.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jul 2021 | 100466596 | Hdfc Bank Limited | ₹79.9 Lakh | Open | |
| 19 Jul 2021 | 100466617 | Hdfc Bank Limited | ₹73.06 Lakh | Open | |
| 07 Jul 2021 | 100456856 | Citi Bank N.A. | ₹2 Cr | Open | |
| 16 Dec 2020 | 100405333 | Hdfc Bank Limited | ₹7 Cr | Open | |
| 19 Feb 2020 | 100330153 | Others | ₹6.25 Cr | Satisfied |
To see the full charge records of Yapan Bio Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Yapan Bio Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹101.77 Cr; the latest was in December 2021.
Total deals
2
Rights issue
1
Funding round
1
Disclosed funding
₹101.77 Cr
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2020 | Rights issue | ₹26 Lakh | Investors: 2 individuals |
To see the full deal history of Yapan Bio Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Yapan Bio Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yapan Bio Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Yapan Bio has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Yapan Bio Private Limited has a workforce of 49 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
49
Active EPFO establishments
1
Employee growth
40%
GST
Yapan Bio has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCY1687M1ZQ | Telangana | Active | 29 Nov 2019 |
To see the full GST registrations and return filing status of Yapan Bio Private Limited, buy the company report.
Recent activity
Yapan Bio Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Debasish Chakravorty was appointed as Nominee Director on 12 Jan 2024.
AGM
Yapan Bio Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Yapan Bio Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Debasish Chakravorty was appointed as Nominee Director.
Ceased
Robert Earl Munday Jr ceased to be Nominee Director.
Ceased
Amit Anant Bapat ceased to be Nominee Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 79.90 Lakh with Charge ID 100466596 was registered on 29 Jul 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 73.06 Lakh with Charge ID 100466617 was registered on 19 Jul 2021.
Charges
A charge with Citi Bank N.A. amounted to Rs. 200.00 Lakh with Charge ID 100456856 was registered on 07 Jul 2021.
Charges
A charge registered on 19 Feb 2020 via Charge ID 100330153 with Others was fully satisfied on 29 Dec 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 700.00 Lakh with Charge ID 100405333 was registered on 16 Dec 2020.
Charges
A charge with Others amounted to Rs. 625.00 Lakh with Charge ID 100330153 was registered on 19 Feb 2020.
Appointed
Atin Tomar was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Yapan Bio is an active private limited company based in Shameerpet, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 October 2019 (7+ years old) and is registered under CIN U74110TG2019PTC136037.
Yapan Bio has 3 current directors:
- Atin Tomar - Director
- Nirav Manoj Kumar Desai - Director
- Debasish Chakravorty - Nominee Director
The latest financial statements of Yapan Bio on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Yapan Bio is 36AABCY1687M1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Yapan Bio is U74110TG2019PTC136037. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yapan Bio was incorporated on 11 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Yapan Bio has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹101.77 Cr; the latest was in December 2021.
Debasish Chakravorty was appointed as Nominee Director on 12 Jan 2024. Robert Earl Munday Jr ceased to be Nominee Director on 11 Jan 2024. Amit Anant Bapat ceased to be Nominee Director on 21 Jan 2022. Yapan Bio has 5 board changes on record in total.
Yes, Yapan Bio is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Yapan Bio is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0005358).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages